Paraneoplastic Pyoderma Gangrenosum Associated with Rectal Adenocarcinoma
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Pyoderma gangrenosum (PG) is a rare chronic neutrophilic dermatosis characterized by painful necrotic ulceration. The most common diseases associated with PG are inflammatory bowel disease, certain rheumatologic and hematologic diseases, and malignancy. Here, we describe the case of a 60-year-old man who presented with pruritic and painful erythematous ulcerative macules and patches on both lower extremities, and was diagnosed with PG based on his clinical and histologic features. His PG became exacerbated despite standard therapy with a high-dose systemic steroid in combination with dapsone and cyclosporine. Systemic evaluation of underlying conditions revealed rectal adenocarcinoma at the rectosigmoid junction (T3N0M0), which was completely removed via Hartmann’s procedure followed by adjuvant chemotherapy. Two months after anticancer therapy, his PG was completely healed with hypertrophic scarring. Herein, we present the first case of paraneoplastic PG caused by rectal adenocarcinoma in Korea.
Abstract
Pyoderma gangrenosum (PG) is a rare chronic neutrophilic dermatosis characterized by painful necrotic ulceration. The most common diseases associated with PG are inflammatory bowel disease, certain rheumatologic and hematologic diseases, and malignancy. Here, we describe the case of a 60-year-old man who presented with pruritic and painful erythematous ulcerative macules and patches on both lower extremities, and was diagnosed with PG based on his clinical and histologic features. His PG became exacerbated despite standard therapy with a high-dose systemic steroid in combination with dapsone and cyclosporine. Systemic evaluation of underlying conditions revealed rectal adenocarcinoma at the rectosigmoid junction (T3N0M0), which was completely removed via Hartmann’s procedure followed by adjuvant chemotherapy. Two months after anticancer therapy, his PG was completely healed with hypertrophic scarring. Herein, we present the first case of paraneoplastic PG caused by rectal adenocarcinoma in Korea.
참고문헌 (16)
- Crowson AN, "Pyoderma gangrenosum: a review", J Cutan Pathol, 30, pp.97~107 (2003)[DOI]
- Magro CM, "A distinctive vesiculopustular eruption associated with hepatobiliary disease", Int J Dermatol, 36, pp.837~844 (1997)[DOI]
- 이재인, "A Case of Pyoderma Gangrenosum with Ulcerative Colitis Treated with Mesalazine", Annals of Dermatology, 22(4), pp.422~425 (2010), 대한피부과학회
- Duguid CM, "Paraneoplastic pyoderma gangrenosum", Australas J Dermatol, 34, pp.17~22 (1993)[DOI]
- Su WP, "Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria", Int J Dermatol, 43, pp.790~800 (2004)[DOI]
- Powell FC, "Pyoderma gangrenosum: classification and management", J Am Acad Dermatol, 34, pp.395~409 (1996)[DOI]
- Mlika RB, "Pyoderma gangrenosum: a report of 21 cases", Int J Dermatol, 41, pp.65~68 (2002)[DOI]
- Gateley CA, "Pyoderma gangrenosum of the breast", Br J Clin Pract, 44, pp.713~714 (1990)
- Gallo R, "Pyoderma gangrenosum in a patient with gastric carcinoma", Int J Dermatol, 34, pp.713~714 (1995)[DOI]
- Basille W, "Pyoderma gangrenosum. Association to acinar cell carcinoma of the parotid gland", Ann Dermatol Venereol, 119, pp.381~383 (1992)
- Bunte C, "Concomitant manifestation of pyoderma gangrenosum and colorectal carcinoma", Scand J Gastroenterol, 43, pp.756~758 (2008)[DOI]
- Regnier-Rosencher E, "Pyoderma gangrenosum associated with renal carcinoma", J Am Acad Dermatol, 64, pp.1208~1211 (2011)[DOI]
- Foley CC, "Paraneoplastic pyoderma gangrenosum successfully treated with minocycline and low-dose steroids", J Eur Acad Dermatol Venereol, 29, pp.184~185 (2015)[DOI]
- Sakai H, "Peristomal pyoderma gangrenosum associated with rectal adenocarcinoma", J Dermatol, 33, pp.68~70 (2006)[DOI]
- Shahi V, "Pyoderma gangrenosum associated with solid organ malignancies", Int J Dermatol, 54, pp.e351~e357 (2015)[DOI]
- Adachi Y, "Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum", J Invest Dermatol, 111, pp.259~268 (1998)[DOI]